# The National Health Service (Cross-Border Health Care) (Scotland) Regulations 2013, Paragraph 4


The details of the prescribed product, including where applicable the—
(a) common name as defined by Article 1 of Directive 2001/83/EC;
(b) brand name if—
(i) the prescribed product is a biological medicinal product as referred to in point 3.2.1.1.(b) of Annex 1 (Part 1) to Directive 2001/83/EC; or
(ii) the prescribing professional deems it medically necessary for that product to be dispensed and, in that case, the prescribing professional’s reasons justifying the use of the brand name;
(c) pharmaceutical formulation (such as tablet, solution etc.);
(d) quantity;
(e) strength as defined in Article 1 of Directive 2001/83/EC; and
(f) dosage regimen.

---
Source: https://www.legislation.gov.uk/ssi/2013/292/schedule/paragraph/4 (the official version)
Page: https://openlegislation.uk/national-health-service-cross-border-health-care-scotland-regulations-2013/schedule/paragraph-4
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.

